Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Huguet to succeed Mayer at Ipsen

Plus: Junshi COO Hui departing, Kaufmann named CSO at Hansa

September 1, 2023 11:04 PM UTC

Ipsen Group (Euronext:IPN; Pink:IPSEY) named Christelle Huguet to succeed EVP and Head of R&D Howard Mayer, who is retiring effective Sept. 22. Huguet joined Ipsen in May 2020 as SVP and head of research, external innovation and early development from X-Chem Inc., where she was CSO. Prior to X-Chem, Huguet was head of internal research at Alexion Pharmaceuticals Inc. 

Zhang Zhuobing and Yao Sheng will assume COO duties at  Shanghai Junshi Biosciences Co. Ltd. (HKEX:1877; Shanghai:688180), following the departure of COO Feng Hui for personal reasons. The company added that it will retain Hui as a technical consultant, to ensure a smooth transition. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article